PNC Financial Services Group’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.5K	Sell	2,232 -431	-16%	-$14.1K	﹤0.01%	3096
2025 Q4	$99.6K	Buy	2,663 +619	+30%	+$20.4K	﹤0.01%	2807
2025 Q3	$56.3K	Sell	2,044 -30	-1%	-$1.03K	﹤0.01%	3138
2025 Q2	$65.5K	Sell	2,074 -41	-2%	-$1.32K	﹤0.01%	2965
2025 Q1	$70.2K	Sell	2,115 -213	-9%	-$7.64K	﹤0.01%	2893
2024 Q4	$80.1K	Buy	2,328 +519	+29%	+$17.8K	﹤0.01%	2818
2024 Q3	$72.4K	Sell	1,809 -12	-0.7%	-$422	﹤0.01%	2864
2024 Q2	$54.9K	Buy	1,821 +325	+22%	+$9.77K	﹤0.01%	2975
2024 Q1	$50.2K	Sell	1,496 -452	-23%	-$14.5K	﹤0.01%	2997
2023 Q4	$62.9K	Buy	1,948 +53	+3%	+$1.48K	﹤0.01%	2855
2023 Q3	$62.1K	Sell	1,895 -4,723	-71%	-$164K	﹤0.01%	2835
2023 Q2	$233K	Buy	6,618 +854	+15%	+$29.5K	﹤0.01%	2099
2023 Q1	$188K	Buy	5,764 +1,579	+38%	+$71.9K	﹤0.01%	2178
2022 Q4	$231K	Buy	4,185 +3,081	+279%	+$169K	﹤0.01%	2015
2022 Q3	$49K	Buy	1,104 +356	+48%	+$17.4K	﹤0.01%	2987
2022 Q2	$36K	Buy	748 +401	+116%	+$18.1K	﹤0.01%	3181
2022 Q1	$17K	Sell	347 -519	-60%	-$21.2K	﹤0.01%	3647
2021 Q4	$37K	Buy	+866	New	+$34.5K	﹤0.01%	3270